Ballew Advisors, Inc Cumberland Pharmaceuticals Inc Transaction History

Ballew Advisors, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$5.31 - $7.0 $29,507 - $38,899	-5,557 Closed	0 $0
Q3 2018 Oct 30, 2018	SELL	$5.5 - $6.3 $236 - $270	-43 Reduced 0.77%	5,557 $31,000
Q1 2018 May 07, 2018	BUY	$6.62 - $7.12 $37,072 - $39,872	5,600 New	5,600 $37,000

2.09M

38.1K

200

Ticker CPIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 14,661,900
Market Cap $21.8M
Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...

Get notified when there are updates to the investment portfolio of Ballew Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ballew Advisors, Inc with notifications on news.